We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-21.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.78B
AUM Growth
-$2.41B
Cap. Flow
+$423M
Cap. Flow %
5.44%
Top 10 Hldgs %
19.24%
Holding
1,167
New
181
Increased
433
Reduced
358
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 22.86%
2 Healthcare 16.25%
3 Financials 14.24%
4 Consumer Discretionary 10.76%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCTI
926
DELISTED
PCTEL, Inc. Common Stock
PCTI
$145K ﹤0.01%
21,834
STXB
927
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$145K ﹤0.01%
+14,026
New +$258K
BE icon
928
Bloom Energy
BE
$61B
$144K ﹤0.01%
27,615
XCUR icon
929
Exicure
XCUR
$10M
$144K ﹤0.01%
+649
New +$205K
DTIL icon
930
Precision BioSciences
DTIL
$181M
$143K ﹤0.01%
+789
New +$207K
HAFC icon
931
Hanmi Financial
HAFC
$940M
$143K ﹤0.01%
+13,166
New +$210K
ELF icon
932
e.l.f. Beauty
ELF
$4.85B
$142K ﹤0.01%
14,430
-75,470
-84% -$1.13M
RVSB icon
933
Riverview Bancorp
RVSB
$107M
$136K ﹤0.01%
27,104
+6,566
+32% +$44K
VYGR icon
934
Voyager Therapeutics
VYGR
$189M
$136K ﹤0.01%
14,901
+2,391
+19% +$27.4K
NBN icon
935
Northeast Bank
NBN
$1.05B
$135K ﹤0.01%
+11,576
New +$210K
FULC icon
936
Fulcrum Therapeutics
FULC
$248M
$134K ﹤0.01%
+11,192
New +$179K
TILE icon
937
Interface
TILE
$1.96B
$132K ﹤0.01%
+17,411
New +$243K
YARW
938
Yarrow Bioscience, Inc. Common Stock
YARW
$22M
$132K ﹤0.01%
14
-2
-13% -$31.4K
ORN icon
939
Orion Group Holdings
ORN
$387M
$131K ﹤0.01%
50,229
-1,877
-4% -$7.51K
ACOR
940
DELISTED
Acorda Therapeutics
ACOR
$130K ﹤0.01%
1,164
-8,951
-88% -$1.76M
AQST icon
941
Aquestive Therapeutics
AQST
$467M
$128K ﹤0.01%
58,473
+33,407
+133% +$127K
ACGN
942
DELISTED
Aceragen Inc
ACGN
$128K ﹤0.01%
5,693
-3,568
-39% -$96.9K
ARD
943
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$126K ﹤0.01%
+10,665
New +$187K
ASPN icon
944
Aspen Aerogels
ASPN
$374M
$122K ﹤0.01%
19,951
BSET icon
945
Bassett Furniture
BSET
$168M
$121K ﹤0.01%
22,284
-21,107
-49% -$234K
AAMI
946
Acadian Asset Management
AAMI
$2.99B
$121K ﹤0.01%
18,973
-50,686
-73% -$438K
NBR icon
947
Nabors Industries
NBR
$1.22B
$120K ﹤0.01%
+6,146
New +$563K
GBL
948
DELISTED
GAMCO Investors, Inc.
GBL
$119K ﹤0.01%
10,865
+300
+3% +$4.81K
EXTN
949
DELISTED
Exterran Corporation
EXTN
$118K ﹤0.01%
24,650
-144,718
-85% -$867K
CRD.B icon
950
Crawford & Co Class B
CRD.B
$489M
$117K ﹤0.01%
18,269
-1,600
-8% -$12.7K

Similar funds

Jacobs Levy Equity Management's Q1 2020 Portfolio in Review

As of Q1 2020, Jacobs Levy Equity Management held 1,167 positions worth $7.78B, down 24% from $10.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jacobs Levy Equity Management deployed $423M of net new capital in Q1 2020, opening 181 new positions and adding to 433 existing holdings. Its largest new stake was Gaming and Leisure Properties: 979,767 shares worth $27.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Amazon, an estimated $60.9M trimmed.

  • Jacobs Levy Equity Management's largest Q1 2020 buy was Gaming and Leisure Properties: 979,767 shares worth $27.1M.
  • Jacobs Levy Equity Management added most to Synchrony in Q1 2020, an estimated $56.1M increase.
  • Jacobs Levy Equity Management's biggest Q1 2020 reduction was Amazon, cutting an estimated $60.9M.
  • Jacobs Levy Equity Management fully exited Willis Towers Watson in Q1 2020, selling an estimated $49.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 19% of its $7.78B portfolio in Q1 2020.
  • Jacobs Levy Equity Management opened 181 new positions and closed 174 in Q1 2020.
  • Jacobs Levy Equity Management's portfolio value fell 24% quarter-over-quarter to $7.78B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.